Cryoport, Inc.
CYRXNasdaq
$16.51
↑ +0.1%Jul 17 close · end-of-day
Price
1Y↑ +121.6%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$823.8M
Enterprise Value
$420.2M
P/E
11.5
P/S
4.5
P/B
1.7
EV/EBITDA
—
PEG
—
FCF Yield
-2.9%
Dividend Yield
—
Revenue (TTM)
$182.9M
Net Income (TTM)
$79.7M
Free Cash Flow (TTM)
-$23.8M
Gross Margin
47.2%
Operating Margin
-21.4%
Net Margin
43.6%
ROE
16.1%
ROIC
-33.9%
Debt / Equity
—
Net Cash
$403.6M
Return 1Y
+122.2%
Company profile
Cryoport, Inc., a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments. CryoPort Express Shippers, which is used to ensure that the stability of shipped biologic commodities is maintained throughout the shipping cycle.
- CEO
- Jerrell W. Shelton
- Sector
- Manufacturing
- Industry
- Pharmaceutical Products
- Employees
- 1,020
- Headquarters
- Tennessee
- Website
- cryoport.com
Management & directors
- Zecchini Edward JChief Digital and Tech Officer
- Stefanovich RobertChief Financial Officer
- Shelton JerrellPresident, CEO
- Sawicki Mark WChief Scientific Officer
Roles derived from SEC Form 4 filings.
Earnings
CYRX Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$47.8M↑ +16.5%
Diluted EPS-$0.25↓ -10.7%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $78.7M | $222.6M | $237.3M | $168.7M | $156.8M | $176.2M |
| Gross profit | $36.3M | $96.6M | $103.9M | $75.3M | $69.7M | $83.1M |
| Operating income | -$30.0M | -$17.8M | -$31.9M | -$100.5M | -$121.7M | -$36.8M |
| Net income | -$32.7M | -$275.5M | -$37.3M | -$99.6M | -$114.8M | $78.3M |
| Diluted EPS | -$1.94 | -$6.18 | -$0.93 | -$2.21 | -$2.49 | $1.40 |
| Operating cash flow | -$14.9M | $8.1M | -$1.9M | -$757,000.00 | -$16.3M | -$8.6M |
| Free cash flow | -$23.8M | -$15.8M | -$24.0M | -$39.5M | -$33.6M | -$25.0M |
| Gross margin | 46.2% | 43.4% | 43.8% | 44.7% | 44.4% | 47.1% |
| Operating margin | -38.1% | -8.0% | -13.4% | -59.6% | -77.6% | -20.9% |
| Net margin | -41.5% | -123.8% | -15.7% | -59.0% | -73.2% | 44.4% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $39.7M | $38.3M | $41.5M | $41.0M | $45.5M | $44.2M | $45.5M | $47.8M |
| Gross profit | $17.7M | $17.4M | $19.5M | $18.6M | $21.4M | $21.3M | $21.7M | $21.9M |
| Operating income | -$78.0M | -$13.4M | -$12.7M | -$7.2M | -$9.6M | -$9.9M | -$10.0M | -$9.6M |
| Net income | -$78.0M | $805,000.00 | -$18.7M | -$12.0M | $105.2M | -$6.9M | -$8.0M | -$10.5M |
| Diluted EPS | -$1.62 | -$0.02 | -$0.42 | -$0.28 | $2.05 | -$0.18 | -$0.19 | -$0.25 |
| Operating cash flow | -$8.0M | $447,000.00 | -$5.5M | -$4.3M | -$7.3M | $2.2M | $919,000.00 | $3.7M |
| Free cash flow | -$11.8M | -$3.8M | -$10.7M | -$7.5M | -$11.7M | -$1.3M | -$4.5M | -$6.2M |
| Gross margin | 44.5% | 45.5% | 47.0% | 45.4% | 47.0% | 48.2% | 47.8% | 45.8% |
| Operating margin | -196.5% | -34.9% | -30.7% | -17.5% | -21.2% | -22.5% | -22.1% | -20.1% |
| Net margin | -196.4% | 2.1% | -45.1% | -29.2% | 231.4% | -15.7% | -17.5% | -22.1% |
Company news
Jun 13, 2026
May 4, 2026
- 76d agoCryoport (CYRX) Q1 2026 Earnings Transcriptfool.com
- 76d agoCryoPort Q1 Earnings Call Highlightsmarketbeat.com
- 76d agoCryoPort, Inc. (CYRX) Reports Q1 Loss, Tops Revenue Estimatesfinance.yahoo.com
- 77d agoCryoport (CYRX) Q2 2025 Earnings Transcriptfool.com
- 77d agoCryoport (CYRX) Q1 2025 Earnings Transcriptfool.com
- 77d agoCryoport (CYRX) Q3 2025 Earnings Transcriptfool.com
- 77d agoCryoport Reports First Quarter 2026 Financial Resultsfinance.yahoo.com
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-11 | ZECCHINI EDWARD J· Chief Digital and Tech Officer | Sale | 33,600 | $14.47 | $486,239.04 | filing |
| 2026-06-11 | ZECCHINI EDWARD J· Chief Digital and Tech Officer | Option exercise | 33,600 | $4.80 | $161,280.00 | filing |
| 2026-06-10 | ZECCHINI EDWARD J· Chief Digital and Tech Officer | Sale | 1,400 | $15.23 | $21,323.96 | filing |
| 2026-06-10 | ZECCHINI EDWARD J· Chief Digital and Tech Officer | Option exercise | 1,400 | $4.80 | $6,720.00 | filing |
| 2026-06-08 | Mandalam Ramkumar | Sale | 23,214 | $15.44 | $358,452.02 | filing |
| 2026-06-05 | HANCOCK DANIEL M | Award | 10,350 | $0.00 | $0.00 | filing |
| 2026-06-05 | BADDOUR LINDA | Award | 10,350 | $0.00 | $0.00 | filing |
| 2026-06-05 | Hariri Robert J | Award | 10,350 | $0.00 | $0.00 | filing |
| 2026-06-05 | Mandalam Ramkumar | Award | 10,350 | $0.00 | $0.00 | filing |
| 2026-06-04 | STEFANOVICH ROBERT· Chief Financial Officer | Sale | 169,427 | $16.27 | $2.8M | filing |
| 2026-04-21 | SHELTON JERRELL· President, CEO | Option exercise | 104,007 | $1.87 | $194,493.09 | filing |
| 2026-04-06 | SHELTON JERRELL· President, CEO | Option exercise | 50,000 | $1.87 | $93,500.00 | filing |
| 2026-03-23 | SHELTON JERRELL· President, CEO | Option exercise | 25,000 | $1.87 | $46,750.00 | filing |
| 2026-03-23 | SHELTON JERRELL· President, CEO | Sale | 2,894 | $8.18 | $23,672.92 | filing |
| 2026-03-23 | Sawicki Mark W· Chief Scientific Officer | Sale | 1,341 | $8.18 | $10,969.38 | filing |
| 2026-03-23 | STEFANOVICH ROBERT· Chief Financial Officer | Sale | 1,094 | $8.18 | $8,948.92 | filing |
| 2026-03-16 | SHELTON JERRELL· President, CEO | Sale | 7,918 | $8.00 | $63,344.00 | filing |
| 2026-03-16 | Sawicki Mark W· Chief Scientific Officer | Sale | 3,235 | $8.00 | $25,880.00 | filing |
| 2026-03-16 | STEFANOVICH ROBERT· Chief Financial Officer | Sale | 2,743 | $8.00 | $21,944.00 | filing |
| 2026-03-16 | ZECCHINI EDWARD J· See Remarks | Sale | 2,014 | $8.00 | $16,112.00 | filing |
| 2026-03-14 | ZECCHINI EDWARD J· See Remarks | Award | 21,322 | $0.00 | $0.00 | filing |
| 2026-03-14 | Sawicki Mark W· Chief Scientific Officer | Award | 22,845 | $0.00 | $0.00 | filing |
| 2026-03-14 | STEFANOVICH ROBERT· Chief Financial Officer | Award | 27,413 | $0.00 | $0.00 | filing |
| 2026-03-12 | STEFANOVICH ROBERT· Chief Financial Officer | Sale | 38,700 | $7.76 | $300,385.53 | filing |
| 2026-03-12 | STEFANOVICH ROBERT· Chief Financial Officer | Option exercise | 87,188 | $1.87 | $163,041.56 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.